Education
2022 - Continues
2022 - ContinuesDoctorate
Istinye University, Lisansüstü Eğitim Enstitüsü, Moleküler Onkoloji (DR), Turkey
2017 - 2020
2017 - 2020Post Doctorate of Medicine
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
2012 - 2016
2012 - 2016Expertise In Medicine
Istanbul University, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Turkey
2005 - 2011
2005 - 2011Undergraduate
Istanbul University, Cerrahpaşa Tıp Fakültesi, İngilizce Tıp, Turkey
Dissertations
2016
2016Expertise In Medicine
MEME KANSERİNDE NEOADJUVAN KEMOTERAPİ YANITINI
PREDİKTE EDEN PATOLOJİK FAKTÖRLER
Istanbul University, Cerrahpaşa Tıp Fakultesi, İç Hastalıkları Anabilim Dalı
2016
2016Expertise In Medicine
Meme kanserinde neoadjuvan kemoterapi yanıtını predikte eden patolojik faktörler
İstanbul University-Cerrahpaşa, Cerrahpasa Faculty Of Medicine, Department Of Internal Medicine
Foreign Languages
B1 Intermediate
B1 IntermediateEnglish
Certificates, Courses and Trainings
2018
2018PSİKOONKOLOJİ 2. DÜZEY KLİNİSYEN EĞİTİMİ
Education Management and Planning
PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ
2017
2017AİLE DANIŞMANLIĞI
Education Management and Planning
ULUDAĞ ÜNİVERSİTESİ-UZAKTAN EĞİTİM
2017
2017İMMUNOONKOLOJİ KURSU
Health&Medicine
TÜRK TIBBİ ONKOLOJİ DERNEĞİ
2017
2017PSİKOONKOLOJİ 1. DÜZEY KLİNİSYEN EĞİTİMİ
Education Management and Planning
PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ
Research Areas
Medicine
Internal Medicine Sciences
Internal Diseases
Oncology
Health Sciences
Academic Positions
2024 - Continues
2024 - ContinuesAssistant Professor
Istanbul University, Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı
2023 - 2024
2023 - 2024Associate Professor
Istanbul Bilim University
2017 - 2020
2017 - 2020Research Assistant
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
2012 - 2016
2012 - 2016Research Assistant
İstanbul University-Cerrahpaşa, Cerrahpasa Faculty Of Medicine, Department Of Internal Medicine
Journal articles indexed in SCI, SSCI, and AHCI
2025
2025Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.
Özkurt E., Ordu C., Özmen T., Ilgun A. S., Soybir G., Celebi F., et al.
World journal of surgery
, 2025 (SCI-Expanded)
2024
2024Outcomes of reconstructive techniques in breast cancer using BCCT. core software
Kurt S., İlgün A. S., Özkurt E., Soybir G., Alço G., Ünal Ç., et al.
World Journal of Surgical Oncology
, vol.22, no.1, 2024 (SCI-Expanded)
2024
2024The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.
Minareci Y., Ak N., Sozen H., Tosun O. A., Kucukgergin C., Aydin F., et al.
Molecular biology reports
, vol.51, no.1, pp.515, 2024 (SCI-Expanded)
2024
2024The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients
Ak N., Tuz Z., Aydin E., Ferhatoğlu F., SARI M., Paksoy N., et al.
Turkish Journal of Medical Sciences
, vol.54, no.1, pp.229-238, 2024 (SCI-Expanded)
2024
2024Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study
Dülgar Ö., Türker S., Başaran G., Araz M., Sümbül A. T., Çağlayan D., et al.
Journal of Chemotherapy
, 2024 (SCI-Expanded)
2023
2023Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients
DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.
Journal of Cancer Research and Clinical Oncology
, vol.149, no.16, pp.14833-14841, 2023 (SCI-Expanded)
2023
2023Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.
The oncologist
, vol.28, no.10, pp.875-884, 2023 (SCI-Expanded)
2023
2023MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS
MİNARECİ Y., AK N., SÖZEN H., Tosun O. A., KÜÇÜKGERGİN C., AYDIN F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, 2023 (SCI-Expanded)
2023
2023The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
Hizal M., Bilgin B., Paksoy N., Atci M. M., KAHRAMAN S., Kilickap S., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, vol.149, no.8, pp.4141-4148, 2023 (SCI-Expanded)
2023
2023Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors
Minareci Y., AK N., Tosun O. A., Sozen H., SAİP P. M., Topuz S., et al.
Journal of Cancer Research and Therapeutics
, vol.19, 2023 (SCI-Expanded)
2023
2023Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
BAŞOĞLU TÜYLÜ T., Sakin A., Erol C., Ozden E., ÇABUK D., Cilbir E., et al.
JOURNAL OF CHEMOTHERAPY
, vol.35, no.2, pp.142-149, 2023 (SCI-Expanded)
2023
2023MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
Unal C., Ozmen T., Ilgun A. S., Ordu C., Ozkurt E., AK N., et al.
BREAST CANCER-TARGETS AND THERAPY
, vol.15, pp.659-669, 2023 (SCI-Expanded)
2023
2023Clinicopathologic characteristics and prognostic factors in patients with male breast cancer: A single tertiary center experience
Dogan I., AYDIN E., AK N., ÖZKURT S., İBİŞ K., ŞÜKRÜOĞLU ERDOĞAN Ö., et al.
Journal of Cancer Research and Therapeutics
, vol.19, no.7, pp.1887-1892, 2023 (SCI-Expanded)
2022
2022Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study
PAKSOY N., KHANMAMMADOV N., DOĞAN İ., FERHATOĞLU F., YILDIZ A., AK N., et al.
Medicine (United States)
, vol.101, no.45, 2022 (SCI-Expanded)
2022
2022The Predictive Importance of Body-Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Emirzeoglu L., Arici S., Sahin A. B., Ocak B., Ak N., Ay S., et al.
BREAST CARE
, 2022 (SCI-Expanded)
2022
2022Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
Hizal M., Bilgin B., Paksoy N., Kilickap S., Atci M. M., KAHRAMAN S., et al.
FUTURE ONCOLOGY
, vol.18, pp.2573-2582, 2022 (SCI-Expanded)
2022
2022The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Hizal M., Bilgin B., Paksoy N., Acikgoz O., Sezer A., Gurbuz M., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, vol.148, no.6, pp.1501-1508, 2022 (SCI-Expanded)
2022
2022Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination.
Dogan I., Paksoy N., Ak N., Vatansever S., Saip P., Aydiner A.
JOURNAL OF CLINICAL ONCOLOGY
, vol.40, no.16, 2022 (SCI-Expanded)
2022
2022Recurrent autoimmune encephalitis related to immune checkpoint inhibitors
Ser M. H., Samanci N. S., Naziye A. K., Aydiner A., Ozkara C.
EPILEPTIC DISORDERS
, vol.24, no.3, pp.609-613, 2022 (SCI-Expanded)
2022
2022Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer
Minareci Y., Sozen H., Ak N., Tosun O. A., Saip P., Salihoglu M. Y., et al.
CHEMOTHERAPY
, vol.67, pp.1-11, 2022 (SCI-Expanded)
2022
2022Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
Cil I., Kucukarda A., Atci M. M., Secmeler S., Paksoy N., Ferhatoglu F., et al.
TUMORI JOURNAL
, vol.108, no.1, pp.19-25, 2022 (SCI-Expanded)
2022
2022Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
Paksoy N., Erdem S., Karaca M., Ak N., Pehlivan M., Yirgin İ., et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
, vol.28, no.1, pp.215-221, 2022 (SCI-Expanded)
2022
2022Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey
Karabulut S., DOĞAN İ., USUL AFŞAR Ç., Karabulut M., Ak N., Duran A., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, vol.28, no.1, pp.127-134, 2022 (SCI-Expanded)
2022
2022First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
Esen S. A., Ergun Y., Erol C., Arikan R., Er M. M., Atci M. M., et al.
Bosnian Journal of Basic Medical Sciences
, vol.22, no.5, pp.818-825, 2022 (SCI-Expanded)
2021
2021Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer
Ak N., Vatansever S.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
, vol.46, no.6, pp.1787-1791, 2021 (SCI-Expanded)
2021
2021Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre Experience
Ferhatoglu F., Amirov F., Ozkan B., Kara M., Toker A., Ak N., et al.
ONCOLOGY RESEARCH AND TREATMENT
, no.11, pp.590-600, 2021 (SCI-Expanded)
2021
2021Nivolumab treatment for metastatic thymic epithelial tumors.
Ak N., Aydiner A.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
, vol.27, pp.1710-1715, 2021 (SCI-Expanded)
2021
2021Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment
Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.
BREAST CARE
, vol.16, no.5, pp.468-474, 2021 (SCI-Expanded)
2021
2021Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center
Ak N., Toker A., Kara M., Ozkan B., Ulker M., Kaba E., et al.
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
, vol.29, no.4, pp.487-495, 2021 (SCI-Expanded)
2021
2021Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY
, vol.19, no.1, 2021 (SCI-Expanded)
2021
2021Skeletal system as a rare metastatic site in patients with ovarian carcinoma
Ak N., Minareci Y., Saip P.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, vol.31, no.8, pp.1125-1131, 2021 (SCI-Expanded)
2021
2021Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.
Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.
JOURNAL OF CLINICAL ONCOLOGY
, vol.39, no.15, 2021 (SCI-Expanded)
2021
2021The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study
Ak N., Ozkan B., Yenigun M. B., Yilmazbayhan D., Toker A., Ferhatoglu F., et al.
JOURNAL OF BUON
, vol.26, no.3, pp.819-829, 2021 (SCI-Expanded)
2021
2021Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors.
Ferhatoglu F., Paksoy N., Dogan I., Ak N., Pehlivan M., Ekenel M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, vol.39, no.15, 2021 (SCI-Expanded)
2021
2021"Door to Treatment" Outcomes of Cancer Patients during the COVID-19 Pandemic
Ak N., Vatansever S.
CHEMOTHERAPY
, vol.65, no.5-6, pp.141-146, 2021 (SCI-Expanded)
2021
2021Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?
Celik E., Kizildag Yirgin I., Goksever Celik H., Engin G., Sozen H., Ak N., et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
, vol.47, no.2, pp.560-569, 2021 (SCI-Expanded)
2021
2021Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
Bahceci A., PAYDAŞ S., Ak N., Ferhatoglu F., Saip P. M., SEYDAOĞLU G., et al.
CANCER INVESTIGATION
, vol.39, no.6-7, pp.473-481, 2021 (SCI-Expanded)
2020
2020Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Alkan A., Yasar A., Guc Z. G., Gurbuz M., BAŞOĞLU TÜYLÜ T., SEZGİN GÖKSU S., et al.
EUROPEAN JOURNAL OF CANCER CARE
, vol.29, no.6, 2020 (SCI-Expanded)
2020
2020Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
Tüzer C., Sarı M., Aktaş Ç., Ak N., Büyüköztürk S., Çolakoğlu B., et al.
ALLERGY
, vol.75, no.11, pp.2942-2946, 2020 (SCI-Expanded)
2019
2019IS CHEMOTHERAPY BETTER FOR EARLY STAGE HIGH RISK HISTOLOGIC TYPES OF ENDOMETRIAL CANCER
ÇELİK E. G., AK N., SÖZEN H., SAİP P. M., TOPUZ S.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, vol.29, 2019 (SCI-Expanded)
2019
2019Outcomes of Thymoma and Determinants of Survival: 16 Years Experience of a Tertiary Cancer Center
Ak N., Toker A., Bayraktar S., Ozkan B., Ülker M. B. C., Dagoglu N., et al.
JOURNAL OF THORACIC ONCOLOGY
, no.10, 2019 (SCI-Expanded)
2019
2019The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
Eralp Y., Ak N., Yilmazbayhan D., Ozkan B., Ferhatoglu F., Demirkazik A., et al.
JOURNAL OF THORACIC ONCOLOGY
, vol.14, no.10, 2019 (SCI-Expanded)
2019
2019Feasibilty of sentinel lymph node biopsy in patients with node-positive inflammatory breast cancer who responded to neoadjuvant systemic treatment
OPREA A. -., Ak N., Saip P., Onder S., Bademler S., Gulluoglu B. M., et al.
BREAST
, vol.44, 2019 (SCI-Expanded)
2019
2019Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.
Keskin S., Kucucuk S., Ak N., ATALAR B., Sari M., Sozen H., et al.
Oncology research and treatment
, vol.42, no.3, pp.101-106, 2019 (SCI-Expanded)
Articles Published in Other Journals
2024
2024Prognostic Value of p16<SUP>INK4A</SUP> and Ki67 Co-expression in Patients with Vaginal Intraepithelial Neoplasia
Minareci Y., AK N., Bayram A., Tosun O. A., Murdan R., Onder S., et al.
INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY
, vol.22, no.2, 2024 (ESCI)
2024
2024The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
Tapan T. K., Çelebi F., Yaghouti K., Aǧaçayak F., Ilgün S., Soybir G., et al.
European Journal of Breast Health
, vol.20, no.2, pp.117-121, 2024 (ESCI)
2024
2024The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience
Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.
Turk Onkoloji Dergisi
, vol.39, no.3, pp.257-264, 2024 (ESCI)
2023
2023Autoimmune hemolytic anemia associated with clear cell renal carcinoma: A case report
Güven S., Ak N.
Journal of Current Hematology & Oncology Research , vol.3, no.1, pp.102-103, 2023 (Peer-Reviewed Journal)
2023
2023Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated with A Combination of Lapatinib and Capecitabine
DOĞAN İ., Paksoy N., AK N., VATANSEVER S., Saip P., AYDINER A.
European Journal of Breast Health
, vol.19, no.2, pp.128-133, 2023 (Scopus)
2023
2023Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital
FERHATOĞLU F., Kapağan T., Paksoy N., Ak N., Medetalibeyoğlu A., Şenkal N., et al.
Turk Onkoloji Dergisi
, vol.38, no.1, pp.82-91, 2023 (ESCI)
2022
2022Predictors of high-grade residual disease after repeat conization in patients with positive surgical margins
Minareci Y., AK N., Tosun O. A., Sozen H., Disci R., Topuz S., et al.
Ginekologia polska
, vol.93, no.12, pp.962-967, 2022 (Scopus)
2021
2021Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer
AK N., PAKSOY N., VELİDEDEOĞLU M., TURNA Z. H., DEMİRELLİ F. H.
Journal of oncological sciences
, vol.7, no.2, pp.42-49, 2021 (Scopus)
2021
2021MINARECI Y., TOSUN Ö., Ak N., SÖZEN H., TOPUZ S., SALIHOGLU M. Y.
Kocaeli Tıp Dergisi
, vol.10, no.3, pp.217-224, 2021 (Peer-Reviewed Journal)
2021
2021Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma
Naziye A. K., Paksoy N., Ferhatoglu F., Aydin E., Dogan I., Bektas E., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, vol.36, pp.438-445, 2021 (ESCI)
2021
2021Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer
Ak N., Serilmez M., Ucuncu M. Z., Bademler S., Vatansever S.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, vol.36, no.2, pp.165-170, 2021 (ESCI)
2021
2021Effect of Astragalus Membranaceus on Patients with Metastatic Non-Small Cell Lung Cancer: A Retrospective Cohort Study
Ak N., Ciftci R., Cabioglu N., Aydiner A.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, vol.36, no.2, pp.215-221, 2021 (ESCI)
Papers Presented at Peer-Reviewed Scientific Conferences
2020
2020Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience
DOĞAN İ., AYDIN E. M., AK N., İBİŞ K., Sukruoglu Ö., Erciyas S., et al.
ESMO Asia Virtual Congress, ELECTR NETWORK, 20 - 22 November 2020, vol.31, (Summary Text)
2019
2019Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
Karabulut S., Dogan I., Ak N., Afsar C. U., Karabulut M., Tastekin D.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.305, (Summary Text)
2019
2019Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
AK N.
European Society for Medical Oncology Congress 2019, Barcelona, Spain, 27 September - 01 October 2019, pp.424-430, (Summary Text)
2019
2019THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY
AK N.
World Conferrence of Lung Cancer 2019, Barcelona, Spain, 7 - 10 September 2019, pp.933-934, (Summary Text)
2019
2019OUTCOMES OF THYMOMA AND DETERMINANTS OF SURVIVAL: 16 YEARS EXPERIENCE OF A TERTIARY CANCER CENTER
AK N.
World Conferrence of Lung Cancer, Barcelona, Spain, 7 - 10 September 2019, pp.1095-1096, (Summary Text)
2019
2019Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
Tuzer O. C., Sari M., Aktas E., Ak N., Buyukozturk S., Colakoglu B., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.737-738, (Summary Text)
2019
2019Significance of adiposity in endometrial cancer prognosis.
KIZILDAĞ YIRGIN İ., ENGİN G., ÇELİK E., TOPUZ S., AK N., SAİP P.
Türk manyetik rezonans derneği.24.Uluslararası katılımlı yıllık bilimsel toplantısı. 2019, Ankara, Turkey, 25 - 27 April 2019, (Full Text)
2018
2018Platin ile hızlı desensitizasyonun sitokin düzeylerine etkisi P -29
Tüzer Ö. C., Sarı M., ÇETİN E., Ak N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.
XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, pp.111, (Full Text)
2013
2013IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu
BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E., AR M. C., et al.
39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 - 26 October 2013, no.261, pp.277-278, (Full Text)
2012
2012IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu
BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E., AR M. C., et al.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, no.261, pp.277-278, (Full Text)
Books
2020
2020Göğüs duvarı tümörlerinde kemoterapi
AK N., Keskin S.
in: Göğüs duvarı hastalıkları ve cerrahisi, Ali Cevat Kutluk, Soner Gürsoy, Editor, Türkiye Solunum Araştırmaları derneği, pp.209-2013, 2020
2019
2019Endometrium Kanserleri
AK N.
in: Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, CİHAN S, GEREDELİ Ç, DEMİR C., Editor, Tıbbi Yayınlar Merkezi, İstanbul, pp.113-122, 2019
2019
2019Systemic Treatment Drugs/Regimens and Dose Modifications
AK N.
in: Breast Disease, Aydiner A., Igci A., Soran A., Editor, Springer, Cham, Isviçre, pp.789-801, 2019
2019
2019Systemic Treatment Drugs/Regimens and Dose Modifications
AK N., AYDINER A.
in: Breast Disease, Adnan Aydiner, Abdullah Igci, Atilla Soran, Editor, Springer Cham, pp.789-801, 2019
2019
2019Timus hastalıklarında kemoterapi
AK N., AYDINER A.
in: Timus hastalıkları ve tedavisi, Dr. Koray Dural, Dr. Berker Özkan, Dr. Berkant Özpolat, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.180-185, 2019
2018
2018Systemic Treatment Drugs and Regimens
AK N.
in: Breast Cancer
A Guide to Clinical Practice, Aydiner A, Igci A, Soran A., Editor, Springer International Publishing, Copyright Holder Springer Nature Switzerland Ag, pp.587-608, 2018
2018
2018Systemic Treatment Drugs and Regimens
AK N., AYDINER A.
in: Breast Cancer, Adnan Aydiner, Abdullah Igci, Atilla Soran, Editor, Springer Cham, pp.587-608, 2018
Peer Reviews in Scientific Publications
September 2019
September 2019